Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the time-to-response between radiotherapy and epidermal growth factor receptor--tyrosine kinase inhibitors for advanced non-small cell lung cancer with EGFR mutation.
Imai H, Shukuya T, Takahashi T, Fujiwara S, Mori K, Ono A, Akamatsu H, Taira T, Kenmotsu H, Naito T, Kaira K, Murakami H, Harada H, Endo M, Nakajima T, Yamamoto N. Imai H, et al. Among authors: akamatsu h. Anticancer Res. 2013 Aug;33(8):3279-84. Anticancer Res. 2013. PMID: 23898092
Differential efficacy of docetaxel according to non-small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors.
Miura S, Murakami H, Tamiya A, Morii S, Akamatsu H, Ono A, Syukuya T, Kenmotsu H, Tsuya A, Nakamura Y, Kaira K, Naito T, Takahashi T, Endo M, Nakajima T, Yamamoto N. Miura S, et al. Among authors: akamatsu h. Oncol Lett. 2011 Nov;2(6):1059-1064. doi: 10.3892/ol.2011.400. Epub 2011 Aug 31. Oncol Lett. 2011. PMID: 22848267 Free PMC article.
Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: a retrospective study in Japan.
Kenmotsu H, Ohde Y, Shukuya T, Eida H, Akamatsu H, Ono A, Nakamura Y, Tsuya A, Kaira K, Naito T, Murakami H, Takahashi T, Maniwa T, Isaka M, Endo M, Kondo H, Yamamoto N. Kenmotsu H, et al. Among authors: akamatsu h. Respir Investig. 2012 Dec;50(4):157-61. doi: 10.1016/j.resinv.2012.09.002. Epub 2012 Oct 27. Respir Investig. 2012. PMID: 23199980
The impact of clinical outcomes according to EGFR mutation status in patients with locally advanced lung adenocarcinoma who recieved concurrent chemoradiotherapy.
Akamatsu H, Kaira K, Murakami H, Serizawa M, Koh Y, Ono A, Shukuya T, Tsuya A, Nakamura Y, Kenmotsu H, Naito T, Takahashi T, Endo M, Harada H, Nakajima T, Yamamoto N. Akamatsu H, et al. Am J Clin Oncol. 2014 Apr;37(2):144-7. doi: 10.1097/COC.0b013e31826e04f9. Am J Clin Oncol. 2014. PMID: 23211219
592 results